Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Merrimack Pharmaceuticals, Inc.
Industry Pharmaceuticals
Founded 2000 in Cambridge, Massachusetts
Headquarters Cambridge, Massachusetts, United States
Number of employees
426 (2016)
Website www.merrimack.com

Merrimack Pharmaceuticals is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer.

Merrimack first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in Europe the following year.

Merrimack was founded by a group of scientists from MIT and Harvard University in 2000.

In 2016, Merrimack had 426 full-time employees, 103 of which had an MD or PhD.

In October 2016, CEO Robert Mulroy resigned and the company announced they would be laying off 20% of its employees. In January 2017, interim CEO Gary Crocker resigned and the board of directors appointed Richard Peters to be president and CEO. Peters previously worked at Sanofi and was a faculty member at Harvard University.

In January 2017, French pharmaceutical company Ipsen announced they would be purchasing Onivyde from Merrimack for approximately $1 billion.

Merrimack has four drugs in clinical development.

Investment goal date:
Dividends reinvested
Merrimack Pharmaceuticals, Inc. MACK report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-27
--
--
Q3 2017
2017-11-09
--
--
Q2 2017
2017-08-09
3.8600
-0.2200
Q1 2017
2017-05-10
-0.2300
-0.2200
Q4 2016
2017-03-01
-0.2500
-0.2500
Q3 2016
2016-11-09
-0.2300
-0.2300
Q2 2016
2016-08-04
-0.4000
-0.4100
Q1 2016
2016-05-02
-0.3300
-0.3200
Q4 2015
2016-02-25
-0.4100
-0.4100
Q3 2015
2015-11-09
-0.3800
-0.3800
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
AXA
784174
BlackRock Fund Advisors
6837786
BlackRock Inc.
11572067
BlackRock Institutional Trust Company, N.A.
3206460
CANNELL PETER B & CO INC
1212478
DEUTSCHE BANK AG\
1168957
FMR LLC
19319568
FRANKLIN RESOURCES INC
3963264
GEODE CAPITAL MANAGEMENT, LLC
999734
GOLDMAN SACHS GROUP INC
1284683
NORTHERN TRUST CORP
1420124
STATE STREET CORP
6611230
TEACHERS ADVISORS INC
1877703
TIAA CREF INVESTMENT MANAGEMENT LLC
6385111
Vanguard Group, Inc
10265752
Major Shareholders
Name Relationship
Total Shares
Holding stocks
CROCKER GARY L
2.8100% (2943961)
MACK /
PORTER MICHAEL E
0.8000% (839448)
MACK / PTC / SMG /
Nash Sarah E
0.9100% (955296)
BLKB / KNL / MACK /
Sinskey Anthony J
0.4000% (422543)
MACK / MBLX /
Sullivan William A.
0.0200% (21596)
AGTC / MACK /
Mulroy Robert J.
1.6100% (1683328)
MACK /
Stewart Edward J.
0.0500% (51385)
MACK /
Fehr Gordon J.
0.2100% (215143)
MACK /
Dresser James van B.
0.1600% (168974)
MACK /
Niyikiza Clet M.
0.1400% (141507)
MACK /
Nielsen Ulrik B.
0.0200% (22681)
MACK /
McClements William M.
0.0100% (14072)
MACK /
Quigley James H.
0.0500% (56500)
HES / MACK / WFC /
Lee Vivian S
0.0600% (65000)
MACK / ZION /
Schoeberl Birgit M.
0.0600% (65657)
MACK /
% ()